Pandox’s CEO Anders Nissen has acquired synthetic options from Pandox’s main shareholders
Pandox’s CEO Anders Nissen has acquired in total 600,000 synthetic options from Eiendomsspar AS, CGS Holding AS and Helene Sundt AS. The options have a term of approx. five years and the issuers have the possibility to, provided that the exercise price is reached, determine whether the options shall be cash settled or entitle to B-shares in Pandox. The options have been acquired on market terms. The price per option is SEK 2.17 and has been calculated in accordance with the Black-Scholes valuation model. The exercise price per option has been set to SEK 154.85, there is a cap per option of SEK 246.53 and the total profit can be a maximum of approx. SEK 55.01 million.
Pandox is not involved in the issuance of the options and no costs are expected to be incurred for Pandox as a result of the options. Being options issued by shareholders, there will not be any dilution for other shareholders.
After the acquisition of options, Anders Nissen holds 371,250 A- and B-shares, which are either held directly or indirectly through a wholly-owned company, and 1,190,877 options.
FOR MORE INFORMATION, PLEASE CONTACT:
Anders Nissen, CEO, +46 (0) 708 46 02 02
Liia Nõu, CFO, +46 (0) 702 37 44 04
Anders Berg, SVP Head of Communications and IR, +46 (0) 760 95 19 40
The information was submitted for publication at 17:10 CEST on 2 September 2020.
Pandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio currently comprises 156 hotels with approximately 35,000 hotel rooms in 15 countries. Pandox’s business is organised into Property Management, which comprises hotel properties leased on a long-term basis to market leading hotel operators, and Operator Activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are listed on Nasdaq Stockholm. www.pandox.se